The visceral adipose tissue derived serine protease inhibitor (vaspin, SERPINA12 according to the serpin nomenclature [1]) was first identified in the Otsuka Long-Evans Tokushima fatty (OLETF) rat type 2 diabetes model [2]. This evidence concerns the gene SERPINA12 and type 2 diabetes mellitus.